NDPACX: a newly defined X-linked Parkinsonian syndrome associated with SLC9A6 hemizygote mutation

Abstract X-linked female-restricted neurodegenerative disorder with Parkinsonian syndrome and cognitive impairment (NDPACX) is a recently recognized clinical entity caused by heterozygous mutations in SLC9A6 on the X chromosome, which encodes the endosomal Na⁺/H⁺ exchanger NHE6 that contributes to endolysosomal trafficking and acidification. While hemizygous SLC9A6 mutations in males cause Christianson syndrome, a severe neurodevelopmental disorder, emerging evidence indicates that female carriers may develop progressive, adult-onset Parkinsonian syndrome variably accompanied by cognitive decline and psychiatric symptoms. These features often resemble those of corticobasal degeneration, progressive supranuclear palsy, and atypical Parkinson’s disease. Although pathological data for NDPACX are currently lacking, mechanistic inferences drawn from Christianson syndrome and animal models implicate endosomal dysfunction, impaired receptor recycling, and tau accumulation, depending on the loss of function. Furthermore, recent findings have linked reduced SLC9A6 expression to the increased vulnerability of the substantia nigra in sporadic Parkinson’s disease, suggesting a broader relevance beyond rare monogenic disorders. In particular, NDPACX represents a model of endolysosomal neurodegeneration that may be related to lysosomal storage diseases or autophagy-related mechanisms commonly implicated in Parkinsonian syndromes. In this review, we summarize the clinical, molecular, and emerging pathological insights into NDPACX and propose that targeting endolysosomal homeostasis may open new therapeutic avenues for both hereditary and idiopathic neurodegenerative diseases characterized by proteinopathies.

• Publication year

  2025

• Venue

  Brain Communications

• Publication date

  2025-11-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/braincomms/fcaf435PMID 41357349PMCID 12676001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SLC9A6-Linked Parkinson Syndrome in Female Heterozygotes Is Associated With PET-Detectable Tau Pathology

  2025cited by this paper
• LRRK2-associated Parkinson’s disease does have alpha-synuclein pathology

  2025cited by this paper
• A Cautionary Note on the Indication for Deep Brain Stimulation in Parkinsonism Patients With SLC9A6 Gene Mutations

  2025cited by this paper
• Genes for endosomal pH regulators NHE6 and NHE9 are dysregulated in the substantia nigra in parkinson's disease.

  2024cited by this paper
• GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease

  2022cited by this paper
• Novel SLC9A6 Variation in Female Carriers With Intellectual Disability and Atypical Parkinsonism

  2022cited by this paper
• Early lysosome defects precede neurodegeneration with amyloid-β and tau aggregation in NHE6-null rat brain.

  2021cited by this paper
• Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensus.

  2021cited by this paper
• Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.

  2021cited by this paper
• ATP13A2 deficiency disrupts lysosomal polyamine export

  2020cited by this paper
• Complex Neurological Phenotype in Female Carriers of NHE6 Mutations

  2019cited by this paper
• The SLC9A-C Mammalian Na+/H+ Exchanger Family: Molecules, Mechanisms, and Physiology.

  2019cited by this paper
• Lysosomes as a therapeutic target

  2019cited by this paper
• Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

  2019cited by this paper
• GBA-Associated Parkinson’s Disease and Other Synucleinopathies

  2018cited by this paper
• A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci

  2017cited by this paper
• Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe.

  2017cited by this paper
• X-linked Christianson syndrome: heterozygous female Slc9a6 knockout mice develop mosaic neuropathological changes and related behavioral abnormalities

  2016cited by this paper
• Parkin Modulates Endosomal Organization and Function of the Endo-Lysosomal Pathway

  2016cited by this paper
• The expanding phenotypic spectrum of female SLC9A6 mutation carriers: a case series and review of the literature

  2016cited by this paper
• A new family with an SLC9A6 mutation expanding the phenotypic spectrum of Christianson syndrome

  2016cited by this paper
• The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy

  2015cited by this paper
• Mutation in VPS35 associated with Parkinson’s disease impairs WASH complex association and inhibits autophagy

  2014cited by this paper
• Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

  2014cited by this paper
• Novel SLC9A6 mutations in two families with Christianson syndrome

  2013cited by this paper
• The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease

  2013cited by this paper
• Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease

  2012cited by this paper
• X-linked Angelman-like syndrome caused by Slc9a6 knockout in mice exhibits evidence of endosomal–lysosomal dysfunction

  2011cited by this paper
• Structural Modeling and Electron Paramagnetic Resonance Spectroscopy of the Human Na+/H+ Exchanger Isoform 1, NHE1*

  2010influential reference
• Natural history of Christianson syndrome

  2010cited by this paper
• A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.

  2010cited by this paper
• SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome.

  2008cited by this paper
• Model Structure of the Na+/H+ Exchanger 1 (NHE1)

  2007cited by this paper
• Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes.

  2006cited by this paper
• Plasticity in the human central nervous system.

  2006cited by this paper
• Evolutionary origins of eukaryotic sodium/proton exchangers.

  2005cited by this paper
• Four Na+/H+ Exchanger Isoforms Are Distributed to Golgi and Post-Golgi Compartments and Are Involved in Organelle pH Regulation*

  2005cited by this paper
• Diversity of the mammalian sodium/proton exchanger SLC9 gene family

  2004cited by this paper
• Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease

  2004cited by this paper
• Human Na(+)/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria.

  2002cited by this paper
• X linked severe mental retardation, craniofacial dysmorphology, epilepsy, ophthalmoplegia, and cerebellar atrophy in a large South African kindred is localised to Xq24-q27

  1999cited by this paper

• No citing papers are available for this paper.